tiprankstipranks
Trending News
More News >
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
US Market

Kalaris Therapeutics (KLRS) Balance Sheet

Compare
368 Followers

Kalaris Therapeutics Balance Sheet

Kalaris Therapeutics's total assets for Q3 2025 were $81.17M, a decrease of -12.57% from the previous quarter. KLRS total liabilities were $39.31M for the fiscal quarter, a -1.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 118.55M$ 118.55M$ 3.33M$ 3.90M$ 286.59M
Total Liabilities
$ 5.24M$ 5.24M$ 48.35M$ 34.17M$ 61.33M
Total Equity Gross Minority
$ 113.31M$ 113.31M$ -45.02M$ -30.27M$ 225.27M
Other Metrics
Currency in USD

Kalaris Therapeutics Debt to Assets